Why is Venmax Drugs & Pharmaceuticals Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0.33%
- Poor long term growth as Net Sales has grown by an annual rate of 200.30% and Operating profit at 10.45% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 0.81 times
2
With ROE of 2, it has a Expensive valuation with a 0.9 Price to Book Value
- ; the PEG ratio of the company is 0.1
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
200.30%
EBIT Growth (5y)
10.45%
EBIT to Interest (avg)
-0.29
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.32
Tax Ratio
19.57%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-8.10%
ROE (avg)
1.20%
Valuation Key Factors 
Factor
Value
P/E Ratio
46
Industry P/E
40
Price to Book Value
0.94
EV to EBIT
17.14
EV to EBITDA
17.14
EV to Capital Employed
0.94
EV to Sales
1.29
PEG Ratio
0.05
Dividend Yield
NA
ROCE (Latest)
1.65%
ROE (Latest)
2.03%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
Technical Movement
9What is working for the Company
NET SALES(Latest six months)
At Rs 7.76 cr has Grown at 206.72%
PBDIT(Q)
Highest at Rs 0.20 cr.
PBT LESS OI(Q)
Highest at Rs 0.20 cr.
PAT(Q)
Highest at Rs 0.12 cr.
-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 0.53 cr
Loading Valuation Snapshot...
Here's what is working for Venmax Drugs
Net Sales - Latest six months
At Rs 7.76 cr has Grown at 206.72%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 0.20 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 0.20 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 0.12 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Venmax Drugs
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 0.53 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents